J Biol Chem, Vol. 275, Issue 11, 7731-7742, March 17, 2000
Structural Analysis of Murine Zona Pellucida Glycans
EVIDENCE FOR THE EXPRESSION OF CORE 2-TYPE O-GLYCANS
AND THE Sda ANTIGEN*
Richard L.
Easton
,
Manish S.
Patankar§,
Frank A.
Lattanzio§,
Trey H.
Leaven§,
Howard R.
Morris
¶,
Gary F.
Clark§¶, and
Anne
Dell
¶
From the
Department of Biochemistry, Imperial College
of Science, Technology and Medicine, London SW7 2AY, United Kingdom and
§ Department of Physiological Sciences, Eastern Virginia
Medical School, Norfolk, Virginia 23501
 |
ABSTRACT |
Murine sperm initiate fertilization by binding to
specific oligosaccharides linked to the zona pellucida, the specialized matrix coating the egg. Biophysical analyses have revealed the presence
of both high mannose and complex-type N-glycans in murine zona pellucida. The predominant high mannose-type glycan had the composition Man5GlcNAc2, but larger
oligosaccharides of this type were also detected. Biantennary,
triantennary, and tetraantennary complex-type N-glycans
were found to be terminated with the following antennae:
Gal
1-4GlcNAc, NeuAc
2-3Gal
1-4GlcNAc,
NeuGc
2-3Gal
1-4GlcNAc, the Sda antigen
(NeuAc
2-3[GalNAc
1-4]Gal
1-4GlcNAc,
NeuGc
2-3[GalNAc
1-4]Gal
1-4GlcNAc), and terminal GlcNAc.
Polylactosamine-type sequence was also detected on a subset of the
antennae. Analysis of the O-glycans indicated that the
majority were core 2-type
(Gal
1-4GlcNAc
1-6[Gal
1-3]GalNAc). The
1-6-linked
branches attached to these O-glycans were terminated with
the same sequences as the N-glycans, except for terminal GlcNAc. Glycans bearing Gal
1-4GlcNAc
1-6 branches have
previously been suggested to mediate initial murine gamete binding.
Oligosaccharides terminated with GalNAc
1-4Gal have been implicated
in the secondary binding interaction that occurs following the acrosome
reaction. The significant implications of these observations are discussed.
 |
INTRODUCTION |
The initial event in the life of all sexually reproducing
metazoans is the fertilization of an individual egg by a single sperm.
Murine sperm begin this process by binding to the specialized extracellular matrix of the egg known as the
mZP1 (1). This matrix has
been shown to be composed of three major glycoproteins (designated
mZP1, mZP2, and mZP3) (2). There is strong evidence to suggest that
binding occurs via the interaction of mZP3-associated glycans with
lectin-like proteins on the sperm surface (3, 4) that in turn induce a
signal transduction event known as the acrosome reaction (5). During
this reaction, the plasma membrane of the sperm fuses with the outer
membrane of a lysosome-like organelle known as the acrosome lying just beneath the surface of the sperm. The resulting membrane complex then
blebs off to expose the inner acrosomal membrane. In the mouse model,
this inner acrosomal membrane then undergoes secondary binding to mZP2.
Sperm move through the mZP and fuse with the egg, thus completing the
process of fertilization.
Initial studies performed by Wassarman and co-workers (3) indicate that
either Pronase glycopeptides (3) or O-linked oligosaccharides (4) obtained from mZP3 block murine sperm-egg binding.
Several major models for the initial murine gamete binding interaction
have subsequently been proposed that are based upon specific
carbohydrate recognition (6-9). A recent study involving recombinant
mZP3 synthesized in murine F9 embryonal carcinoma cells suggests that
vicinal presentation of O-linked oligosaccharides within a
specific region of mZP3 is necessary for initial sperm-egg binding
(10). mZP2 has been proposed to be the glycoprotein that mediates the
secondary binding interaction involving binding to the inner acrosomal
membrane (11). This binding event has also been postulated to rely upon
carbohydrate-mediated interactions (12).
Structural analysis of mZP2 and mZP3-associated glycans has previously
been performed using radioactive (13) and fluorescent (14) detection
methods. However, precise compositional and linkage data related to
these oligosaccharides could not be obtained by employing such
techniques. The present study was undertaken to obtain this information
using high sensitivity mass spectrometric techniques. We report
evidence for the presence of the Sda antigen in both the
N- and O-linked oligosaccharides derived from
murine ZP. The O-glycans detected in this analysis are
primarily of the core 2 glycan type. Potential structure-function
relationships emerging from this new structural information will be
discussed in depth.
 |
EXPERIMENTAL PROCEDURES |
Purification of Murine ZP--
The method that was employed for
zona purification was a modification of an existing procedure kindly
provided by Dr. Jeffrey Bleil.2 Flash-frozen mouse
ovaries were obtained from Harlan Bioproducts for Science
(Indianapolis, IN) and stored at
80 °C until processed. The total
number of ovaries used in this study was 4,000, processed in batches of
40-50 ovaries each. Each batch was thawed and suspended in 6 ml of
ice-cold triethylamine-NaCl buffer (25 mM triethylamine, pH
8.5, containing 150 mM NaCl, 1 mM
CaCl2, and 0.02% NaN3). Turkey egg white
trypsin inhibitor, DNase I, and hyaluronidase (Sigma) were added to
this solution to give final concentrations of 1, 0.1, and 0.1 mg/ml,
respectively. The solution was homogenized with a Polytron homogenizer
until the ovaries were particulate. The mixture was adjusted to 1%
(v/v) Nonidet P-40 by the addition of a 20% solution of this detergent
in triethylamine-NaCl buffer. The solution was treated briefly with the
Polytron homogenizer and then transferred to a Dounce homogenizer. The
solution was further homogenized until liquified and adjusted to a 1%
concentration of deoxycholate by the addition of a 20% solution of
this detergent in triethylamine-NaCl buffer. The solution was further
homogenized until the mixture became opalescent. 3.8 mls of 90%
Percoll in triethylamine-NaCl buffer was added to a 10-ml sealable
Ultracentrifuge tube. The homogenate was carefully layered on the
Percoll solution without mixing. A solution of 35% Percoll in
triethylamine-NaCl buffer was carefully layered on top of the
homogenate. The tube was centrifuged in Sorvall SS-34 rotor at 19,000 rpm for 60 min at 18 °C. An identical sham tube containing the same
solutions was prepared and supplemented with Percoll gradient indicator beads. The length and/or the speed of the run was adjusted so that the
top blue bands of beads (specific gravity = 1.018) migrated at
least 2/3 of the way to the top of the gradient. The position of the
blue beads matched the migration of the zonae in the Percoll gradient.
The zonae (4,000-5,000) were carefully removed with a syringe in a
volume of roughly 0.5 ml.
A small aliquot (5-10 µl) of each preparation was subjected to
visual inspection under an Olympus phase contrast microscope to confirm
the presence of zonae. The purity of the preparation was also confirmed
using the same criteria established in the original isolation procedure
published by Bleil and Wassarman (2).
The purified zona preparation was transferred to a 15-ml centrifuge
tube that was adjusted to a volume of 13 ml with phosphate-buffered saline (20 mM sodium phosphate, pH 7.4, containing 0.15 M NaCl and 0.02% NaN3). After gentle mixing,
the solution was centrifuged at 500 × g for 15 min to
pellet the zonae. This step had to be repeated 12 more times to remove
all residual detergent that could interfere with the biophysical
analysis of the zona glycans. The zonae were resuspended in 1 ml of
phosphate-buffered saline and stored at
20 °C until subjected to
further analysis.
Tryptic Digestion of Murine ZP--
Suspensions of murine ZP
were centrifuged at 2600 × g for 30 min to precipitate
this extracellular matrix. The ZP pellet was resuspended in 800 µl of
50 mM ammonium hydrogen carbonate, pH 8.5. This ZP
suspension was digested with 20 µg of trypsin (EC 3.4.21.4, Sigma)
for 5 h at 37 °C. 20 µg of trypsin was added, and the
digestion was allowed to proceed at 37 oC for 16 h.
The sample was placed in boiling water for 2 min to terminate the
reaction and lyophilized.
PNGase F Digestion--
The tryptic digest was dissolved in 200 µl of 50 mM ammonium hydrogen carbonate, pH 8.5, and
incubated with PNGase F (EC 3.5.1.52, Roche) at 37 °C overnight to
release N-linked oligosaccharides. The products were
lyophilized and subjected to reverse phase chromatography on a C18
Sep-Pak cartridge exactly as described previously (15) to separate
released oligosaccharides from peptides and
O-glycopeptides.
Reductive Elimination--
The 20% and 40% 1-propanol Sep-Pak
fractions obtained from the purification of the PNGase F digestion were
dissolved in 200 µl of a solution of sodium borohydride (10 mg/ml) in
0.05 M NaOH and incubated at 45 °C for 16 h. The
reactions were terminated by the addition of glacial acetic acid.
Released O-glycans were purified by Dowex as described
previously (15).
Permethylation of Released Glycans and Preparation of Partially
Methylated Alditol Acetates--
Permethylation was performed using
the sodium hydroxide/methyl iodide procedure exactly as established
previously (15). The permethylated N- and
O-glycans were purified by Sep-Pak chromatography using an
established method (15). Preparation of partially methylated alditol
acetates was performed as described (16).
Glycosidase Digestions--
The purified N-glycans
were subjected to digestion with specific glycosidases to discern
relevant structural features. Digestion with endo-
-galactosidase
from Bacteroides fragilis (EC 3.2.1.103, Roche Molecular
Biochemicals) was performed with 10 milliunits of enzyme in 200 µl of
50 mM ammonium acetate, pH 5.5, for 24 h at 37 °C.
Terminal Gal
1-3Gal sequences were hydrolyzed by treatment with 10 milliunits of
-galactosidase from green coffee beans (EC 3.2.1.22,
Roche Molecular Biochemicals) in 200 µl of 50 mM ammonium
acetate, pH 6.0, for 24 h at 37 °C. Jack bean
-mannosidase (EC 3.2.1.24, Roche Molecular Biochemicals) (0.5 units) digestion was
performed under conditions identical to those used for
endo-
-galactosidase digestion. The
-sialidase from
Arthrobacter ureafaciens (EC 3.2.1.18, Glyko, Inc.) (0.2 units) was incubated with the glycans in 200 µl of 100 mM
sodium acetate, pH 5.0, at 37 °C for 48 h. Digestion with
Streptomyces plicatus
-N-acetylhexosaminidase
(recombinant fusion protein, New England BioLabs) was performed with 50 units of enzyme in 200 µl of 50 mM ammonium acetate, pH
4.5, at 37 °C for 24 h.
FAB-MS Analysis--
FAB mass spectra of permethylated
oligosaccharides were acquired using a ZAB-2S.E.-2FPD double-focusing
mass spectrometer fitted with a cesium ion gun operating at 30 kV. Data
analysis was performed using VG Analytical Opus®software.
Solvent and matrices were as described previously (15).
GC-MS Analysis--
GC-MS analysis was performed on a Fisons
Instruments MD800 machine. Separation was achieved using an RTX-5 fused
silica capillary column (30 m × 0.25 mm, Restek Corp). Partially
methylated alditol acetates were dissolved in hexanes and loaded
directly onto the column at 65 °C. The column was held at 65 °C
for 1 min and then increased to 290 °C at a rate of 8 °C/min.
 |
RESULTS |
Isolation and Characterization of ZP--
Murine ZP were isolated
by a modification of an original procedure (2) provided to us by Dr.
Jeffrey Bleil (Scripts Research Institute, La Jolla, CA). Visual
analysis of the preparation indicated the presence of individual zonae
exactly as was observed in the original isolation. SDS-gel
electrophoresis of the isolated ZP using the same conditions employed
in this earlier study indicated the presence of three major diffuse
bands consistent with molecular weights of mZP1, mZP2, and mZP3
proposed earlier (2) (data not shown). Based on these criteria, the
isolated zonae were subjected to carbohydrate structural analysis.
Mapping of the N-Glycan Population--
Purified ZP were digested
with trypsin and incubated with PNGase F to release
N-glycans. The oligosaccharides were separated from peptides
and glycopeptides via reverse phase chromatography on a C18 Sep-Pak
cartridge. The N-glycans were permethylated and separated
from other reactants and products by a second step of Sep-Pak reverse
phase purification (15).
The permethylated glycans were subjected to FAB-MS analysis using an
established method (15). The data indicated the presence of a range of
N-glycans of both the high mannose and complex-types (Fig.
1, Table
I). The following structural features
were evident. (i) The most abundant component was the high mannose
structure Hex5HexNAc2 indicated by the
molecular ion at m/z 1580. Lower levels of larger
high mannose-type glycans (Hex6-9HexNAc2) were
also indicated by the presence of molecular ions at
m/z 1784, 1988, 2192, and 2396 (ii) Complex-type
biantennary N-glycans decorated with fucose and
N-acetylneuraminic acid were also found
(Hex5HexNAc4Fuc at m/z
2244; NeuAcHex5HexNAc4 at
m/z 2432, NeuAc2Hex5HexNAc4Fuc at
m/z 2966). (iii) Some of these biantennary
glycans contain N-glycolylneuraminic acid, as indicated by
signals consistent with NeuGcHex5HexNAc4
(m/z 2462),
NeuGcHex5HexNAc4Fuc (m/z
2636), and NeuGc2Hex5HexNAc4Fuc
(m/z 3027). The presence of
N-glycolylneuraminic acid was also confirmed by the
detection of A-type fragment ions at m/z 855 (NeuGcHexHexNAc+) and m/z 406 (NeuGc+). (iv) Both N-acetylneuraminic acid and
N-glycolylneuraminic acid can be located on the same
N-glycan, as indicated by the molecular ion at
m/z 2996, consistent with
NeuAcNeuGcHex5HexNAc4. (v) Minor amounts of
lactosamine repeats are present, as indicated by the ion at
m/z 913 (Hex2HexNAc2+). (vi) A fragment ion
at m/z 668 (Hex2HexNAc+)
is consistent with the presence of terminal Gal
1-3Gal. (vii) The
presence of A-type ions at m/z 1070 and
m/z 1100 suggest unusual terminal epitopes with
the compositions NeuAcHexHexNAc2+ and
NeuGcHexHexNAc2+, respectively.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 1.
FAB mass spectrum of permethylated
N-glycans from murine zona pellucida. a,
molecular ion region; b, fragment ion region.
N-Glycans released by PNGase F from tryptic glycopeptides
were purified by Sep-Pak, permethylated, and cleaned up by a second
step of Sep-Pak purification before FAB-MS analysis.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Assignments of FAB-MS peaks observed for the molecular and fragment
ions of the permethylated N-glycans released from murine zona pellucida
|
|
Linkage Analysis of Released Murine ZP
N-Glycans--
Permethylated N-glycans were
acid-hydrolyzed, deuteroreduced, and peracetylated. The resulting
partially methylated alditol acetates were analyzed by GC-MS (Table
II). Notable features of the methylation
analysis were the presence of 3,4-disubstituted galactose and terminal
N-acetylgalactosamine. The detection of 2 (major)-, 2,4 (minor)-, and 2,6 (minor)-linked mannose indicated that tri- and
tetraantennary structures were present in addition to the major
biantennary structures. Bisected-type glycan structures also exist, as
shown by the presence of 3,4,6-linked mannose, albeit as very minor
components.
View this table:
[in this window]
[in a new window]
|
Table II
GC-MS analysis of the partially methylated alditol acetates obtained
from the N-glycans of murine zona pellucida
|
|
Endo-
-galactosidase Digestion of Murine ZP
N-Glycans--
To analyze the terminal structures of the minor
polylactosamine-containing N-glycans, PNGase F-released
N-linked oligosaccharides were digested with
endo-
-galactosidase. After digestion, a fraction of the
reaction products was permethylated, separated from contaminants by
reverse phase separation on a Sep-Pak cartridge, and analyzed by
FAB-MS. The data (Fig. 2, Table
III) indicate the presence of several
components not observed before digestion. These components represent
the antennae of complex N-glycans bearing a range of different terminal structures. The high mannose-type structures and
shorter complex structures were unaffected by this enzyme treatment.
Because of the specificity of the enzyme, the oligosaccharides released
from the nonreducing termini of polylactosamine-containing antennae all
have a reducing Gal residue. Thus, significant signals were observed at
m/z 926 (Hex2HexNAc1-Gal), which likely represents structures terminating in
-linked galactose,
m/z 1328 (NeuAcHex1HexNAc2-Gal), and its
N-glycolylneuraminic acid counterpart at
m/z 1358 (NeuGcHex1HexNAc2-Gal). The large signal at
m/z 518 represents the disaccharide GlcNAc-Gal, the major product expected after endo-
-galactosidase of
polylactosamine-type chains.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 2.
FAB mass spectra of the products of digestion
of N-glycans from murine zona pellucida with
endo- -galactosidase. a, 35%
acetonitrile Sep-Pak fraction; b, 50% acetonitrile Sep-Pak
fraction. After digestion, the products were permethylated and purified
by Sep-Pak before mass spectrometric analysis.
|
|
View this table:
[in this window]
[in a new window]
|
Table III
Assignments of the molecular ions observed in the FAB mass spectra of
murine zona pellucida N-glycans following digestion with
endo- -galactosidase and permethylation
|
|
Confirmation That
-Linked Galactose Is Associated with Murine ZP
Glycans--
The products of endo-
-galactosidase digestion were
further digested with
-galactosidase, permethylated, and analyzed by FAB-MS. The signal at m/z 926 (Fig. 2) was absent
after
-galactosidase digestion (data not shown), demonstrating that
it contained
-linked galactose.
Confirmation of the Presence of High Mannose-type N-Glycans on
Murine ZP--
Another aliquot of the endo-
-galactosidase-treated
N-glycans was digested with
-mannosidase. The products of
the digestion were analyzed by FAB-MS after permethylation. All signals
corresponding to the high mannose-type sequences were absent, but those
of the complex structures were still detected (Fig.
3). This result is consistent with the
presence of high mannose-type sequences in this mixture.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 3.
FAB mass spectrum of the products of
sequential digestion of N-glycans from murine zona
pellucida with endo- -galactosidase and
-mannosidase. After digestion, the products
were permethylated and purified by Sep-Pak before mass spectrometric
analysis. For assignments of the signals, see Table I. Note the absence
of signals corresponding to high mannose structures.
|
|
Identification of the Sda Determinant on Murine ZP
N-Linked Oligosaccharides--
The A-type fragment ions at
m/z 1070 and m/z 1100 observed in the N-glycan mapping experiment have
compositions consistent with the Sda determinant
(GalNAc
1-4(NeuAc
2-3)Gal
14GlcNAc) and its
N-glycolylneuraminic acid counterpart. In addition, the
results of the linkage analysis and endo-
-galactosidase experiments
support the presence of this epitope (see above). Further information
on the structures of these epitopes was obtained from the following
experiments. FAB-MS of the permethylated reaction products of
-sialidase digestion of the PNGase F-released murine ZP
N-glycans showed the release of both
N-acetylneuraminic acid and N-glycolylneuraminic
acid (Fig. 4, Table
IV). Thus the fragment ions attributable
to NeuAc-containing structures originally detected in the undigested
N-glycans at m/z 376, m/z 825, and m/z 1070 were
absent after digestion. The NeuGc-containing structures showed
differing susceptibilities to the sialidase. The linear structure
NeuGcHexHexNAc+ was fully digested as shown by the absence
of m/z 855, but the potentially branched
sequence, NeuGc[HexNAc]HexHexNAc, which is detected as an A-type ion
at m/z 1100, was still present after digestion. A
new fragment ion was present at m/z 709, corresponding to HexHexNAc2+, the expected ion
produced after the removal of N-acetylneuraminic or
N-glycolylneuraminic acid from the Sda
determinant. The small signal present at m/z 1362 demonstrated the presence of low levels of polylactosamine repeats.
This signal was not observed before sialidase digestion, demonstrating
that the polylactosamine repeats are capped with
N-acetylneuraminic acid or N-glycolylneuraminic
acid. Linkage analysis of the products of digestion confirmed the
reduction in abundance of 3,4-linked galactose and an increase in
4-linked galactose.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4.
FAB mass spectrum of the products of
digestion of N-glycans from murine zona pellucida
with -sialidase. a, molecular
ion region; b, fragment ion region. After digestion, the
products were permethylated and purified by Sep-Pak before mass
spectrometric analysis.
|
|
View this table:
[in this window]
[in a new window]
|
Table IV
Assignment of the molecular and fragment ions observed in the FAB mass
spectrum of murine zona pellucida N-glycans following digestion with
-sialidase and permethylation
|
|
To provide further evidence for the putative Sda structure,
an aliquot of the endo-
-galactosidase-treated murine ZP
N-glycans was digested with
-sialidase. A portion of this
reaction mixture was permethylated and analyzed by FAB-MS (Fig.
5a). The data indicated that
N-acetylneuraminic acid had been removed (loss of
m/z 1328), the signal at
m/z 1358 (NeuGcHex1HexNAc2-Gal) had been reduced in
intensity, and a new signal had appeared at m/z
967, corresponding to
Hex1HexNAc2-Gal+Na+.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
FAB mass spectra of the products of
sequential digestion of N-glycans from murine zona
pellucida with endo- -galactosidase and
-sialidase (a) and
-sialidase (b) followed by
-N-acetylhexosaminidase.
After digestion, the products were permethylated and purified by
Sep-Pak before mass spectrometric analysis.
|
|
The remainder of the
-sialidase-treated fraction was further
digested with
-N-acetylhexosaminidase. An aliquot was
removed for permethylation and FAB-MS analysis (Fig. 5b).
The data showed significant reduction of the signal at
m/z 967 (Hex1HexNAc2-Gal+Na+) and the loss
of the signal at 518 (GlcNAc-Gal+Na+). The new minor signal
at m/z 1171 (Hex3HexNAc2+Na+) is due to the
loss of N-acetylglucosamine from truncated complex structures. To confirm that N-acetylgalactosamine was
removed, linkage analysis was performed on the
-sialidase-treated
N-glycans and on the
-sialidase plus
-N-acetylhexosaminidase-treated glycans. Comparison of
the data indicated that terminal N-acetylgalactosamine was
present before
-N-acetylhexosaminidase digestion but was absent afterward. N-Acetylglucosamine continued to be
detected after
-N-acetylhexosaminidase digestion, data
that are consistent with the assignments of structures present in the
FAB-MS spectrum after this full range of enzyme digests. Taken
together, the above data provide convincing evidence for the presence
of the Sda epitope and its N-glycolylneuraminic
acid counterpart on polylactosamine antennae of complex-type
N-glycans in the murine ZP.
Assignment of N-Glycan Structures--
Taking into account all the
above data, the major N-glycans in the murine ZP preparation
are assigned the structures in Fig. 6.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 6.
Structures proposed for the major
N-glycans present on murine zona pellucida.
a, mannose residues present in 1-2 linkage.
b, GlcNAc may be linked to either arm, forming a
triantennary structure (1-4 or 1-6 linkage) or the core -linked
mannose to form a bisected structure (1-4 linkage). c,
monosaccharide may be attached to any arm ( 2-3 linkage). Open
circles, mannose; closed circles, galactose;
inverted open triangles, fucose; open squares,
GlcNAc; open ovals, NeuAc; striped
ovals, NeuGc.
|
|
Mapping of the O-Glycan Population--
Murine ZP were digested
with trypsin and subjected to N-glycanase digestion. After
separation of released N-glycans from peptides and
glycopeptides on a Sep Pak C18 cartridge, the glycopeptides eluting in
20% and 40% n-propanol were subjected to reductive elimination, Dowex purification, borate removal, permethylation, reverse phase separation, and FAB-MS analysis. The data obtained (Fig.
7, Table V)
were consistent with the following structural assignments: (i) the
presence of a range of reduced O-glycans, the majority of
which are composed of from 3 to 6 monosaccharide residues; (ii) pairs
of molecular ions separated by 30 mass units whose compositions are
consistent with the presence of both N-acetylneuraminic acid
and N-glycolylneuraminic acid (m/z
873/903, 1256/1286, 1344/1374, 1590/1620); fragment ion data gives
further evidence for the presence of these monosaccharides
(m/z 825/855); (iii) ions at
m/z 1070 and m/z 1100 whose
compositions suggest the possible presence of the Sda
epitope, which is of particular interest; (iv) no observation of
fucosylated O-glycans nor any evidence for the presence of lactosamine repeats; and (v) a weak signal at m/z
668 (Hex2HexNAc+), most likely derived from the
molecular ion at m/z 1165, providing evidence for
the presence of the Gal
1-3Gal epitope.

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 7.
FAB mass spectrum of the permethylated
O-glycans from murine zona pellucida. Tryptic
glycopeptides derived from murine zona pellucida were treated with
PNGase F followed by reductive elimination of the Sep-Pak-purified
O-glycopeptides, Dowex purification, borate removal,
permethylation, Sep-Pak clean up and FAB-MS analysis. The
inset shows the region from m/z 950 to
m/z 1300 following the addition of a small amount
of acid to enhance A-type ion formation.
|
|
View this table:
[in this window]
[in a new window]
|
Table V
Assignment of FAB-MS peaks observed for the molecular and fragment ions
of the permethylated O-glycans released from murine zona pellucida
|
|
Linkage Analysis of Released Murine ZP
O-Glycans--
Permethylated O-glycans were
acid-hydrolyzed, deuteroreduced, acetylated, and analyzed by GC-MS
(Table VI). The presence of 3-linked
galactose and the absence of 6-linked galactose indicates that both
N-acetylneuraminic acid and N-glycolylneuraminic
acid are 3-linked to this monosaccharide. A weak spectrum was obtained for 3,4-linked galactose, providing further evidence that the Sda structure is expressed in the O-glycans.
Although the O-glycan preparation is contaminated with low
levels of N-glycans as indicated by the signals for high
mannose structures in Fig. 6 and the variously linked mannoses in the
linkage data (Table VI), it is unlikely that the 3,4-linked galactose
is derived from N-glycan contaminants. This conclusion is
arrived at by taking into consideration the low levels of
Sda containing N-glycans in the total
N-glycan population and the fact that complex-type
N-glycans were not detectable in the FAB spectra of the
O-glycan preparation.
View this table:
[in this window]
[in a new window]
|
Table VI
GC-MS analysis of the partially methylated alditol acetates obtained
from the O-glycan preparation of murine zona pellucida
|
|
Assignment of O-Glycan Structures--
Rigorous characterization
of each of the O-glycans is particularly challenging because
of the low levels of material available and the complexity of the
O-glycan population. Nevertheless some firm conclusions can
be drawn from the data. In particular the observation of 3,6-linked
GalNAcitol and the absence of detectable levels of 3-linked GalNAcitol
in the linkage analysis indicate that the majority of
O-glycans are likely to have core-type 2 structures. Fig.
8 shows the sequences that have been
assigned from the FAB and linkage data.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 8.
Structures proposed for the major
O-glycans present on murine zona pellucida.
a, monosaccharide may be attached to either the 3 or 6 branch of the O-glycan. Closed squares, GalNAc;
closed circles, galactose; open squares, GlcNAc;
open ovals, NeuAc; striped ovals, NeuGc
|
|
 |
DISCUSSION |
This report outlines the first characterization of murine ZP
glycans using very sensitive biophysical methods of analysis to
determine their precise structural features. Structural analysis of
glycans derived from mZP2 and mZP3 have been performed in previous studies (13, 14). However, because of the analytical methods used,
these investigations did not provide the explicit kind of data that was
generated in the present study. The findings reported in this study are
crucial because the mouse is the most flexible mammalian model for
experimental manipulation. Therefore this study provides complementary
data that may now finally enable the murine gamete binding interaction
to be understood at the molecular level. As will be discussed, this
information may also provide more insight into potential immunological
relationships present in the eutherian reproductive system.
The proposed structures for the major N-linked
oligosaccharides in mZP are shown in Fig. 6. Based on the current
study, the majority of the glycans associated with this extracellular
matrix are primarily high mannose and biantennary complex glycans, with lesser amounts of tri- and tetraantennary complex-type
oligosaccharides. The complex N-glycans exhibit a range of
terminal structures, the great majority of which have been previously
identified during an investigation of mZP2- and mZP3-derived
N-glycans (14). Our data confirm the conclusion of Noguchi
and Nakano (14) that polylactosamine sequences and terminal
-linked
galactose are associated with mZP glycoproteins. An additional
structural feature revealed in our work is the presence of the
Sda antigen on a subset of the glycans, a sequence not
reported in the earlier structural analysis (14). However, Noguchi and
Nakano were required to remove sialic acid from the acidic glycans
associated with mZP2 and mZP3 before obtaining structural analysis of
the core sequences (14). These investigators reported the presence of
terminal GalNAc
1-Gal
1-4GlcNAc (terminal GalNAc linkage not defined) on 4% of the terminal sequences associated with mZP3 (14).
This nonreducing trisaccharide sequence would be the predicted product
resulting from desialylation of the Sda antigen. In
addition, the current analysis has provided strong biophysical evidence
for the Sda antigen containing the less common
N-glycolylneuraminic acid derivative. These findings
highlight the importance of performing structural analysis on intact
carbohydrate structures rather than after specific glycosidase treatments.
The proposed structures for the O-linked oligosaccharides
are shown in Fig. 8. Like the N-linked oligosaccharides,
O-glycans of the murine ZP are very heterogeneous and carry
the same range of terminal structures as the complex-type
N-glycans. The majority of the glycans are core 2 structures
(Gal
1-4GlcNAc
1-6[Gal
1-3]GalNAc) terminated with one or
two N-acetyl or N-glycolylneuraminic acid residues. A notable feature of the O-glycan population is
the presence of components containing the Sda antigen and
its N-glycolylneuraminic acid-containing counterpart.
The results of the present structural analysis are also consistent with
lectin binding studies previously performed on mZP. A potential
carbohydrate ligand was identified for virtually all the lectins that
have been shown to bind to this extracellular matrix (Table
VII) (17-19). For example,
oligosaccharides terminated with the Sda antigen have
previously been shown to bind to Dolichos biflorus agglutinin (20). In addition, lectins that did not bind to ZP (e.g. Ulex europaeus) do not have a corresponding ligand
expressed in the mZP glycans (17).
Another very significant observation is that the lectins from D. biflorus and Griffonia simplicifolia do not bind to the
outer surface of the mZP, inferring that oligosaccharides terminated with either the Sda antigen or
1-3-linked Gal are not
expressed in this region of initial sperm contact (17-19). Skutelsky
et al. (17) also report that Ricinus communis
agglutinin-I, a lectin specific for terminal
-linked Gal, was
specifically bound to the outer surface of the mZP but not the inner ZP
(17). Therefore the outer surface of the mZP could be differentially
glycosylated from the inner ZP. Another possibility is that murine ZP
glycans are modified before fertilization. In the human, there is
evidence suggesting that a sperm surface-associated neuraminidase
exists that is activated by a specific uterine glycoprotein (21).
Removal of sialic acid from the surface of the human ZP results in a
3-fold increase in sperm binding to this matrix in the hemizona assay
system (22). By comparison, neuraminidase treatment of murine eggs
results in only a 30-40% increase in binding (23). Therefore it would not be unreasonable for murine ZP glycans to undergo modification in
the interim between ovulation and fertilization that would promote
initial sperm-egg binding.
Structural analysis of the oligosaccharides associated with porcine ZP
has been carried out in several laboratories. Groups led by Yurewicz
(24), Kobata (25, 26), Vliegenthart (27, 28), Nakano (14, 29-37), and
Takasaki (38) have analyzed the carbohydrate sequences associated with
this matrix. The majority of the N- and O-linked
oligosaccharides express extended polylactosamine chains of
heterogeneous size that are highly substituted with sulfate groups and
sialic acid at their terminal ends. Both N-linked (30) and
O-linked oligosaccharides (24) have been proposed to act as
ligands for sperm binding. The exact oligosaccharide sequences that
mediate binding have not been determined unequivocally. However, it is
certainly apparent from this study and from previous analyses (13, 14)
that the carbohydrate chains linked to porcine and murine ZP
glycoproteins are very different. Therefore some specificity of binding
may be mediated by differential glycosylation.
Evidence obtained in many studies indicates that the carbohydrate
sequences associated with mZP play significant functional roles in
murine gamete binding and fertilization. Wassarman and co-workers (3,
4) provide the first evidence that initial murine gamete binding
involves carbohydrate recognition. This finding led to the development
of several different hypothetical models to explain the molecular basis
for this interaction.
Bleil and Wassarman (7) originally proposed that initial binding was
mediated by ZP3-associated O-glycans terminated with Gal
1-3Gal sequences. Our study provides further evidence for the
presence of these sequences in mZP. However, transgenic mice lacking
the
1-3-galactosyltransferase retain their fertility (39) and
display normal gamete binding (40). Therefore it is doubtful that this
terminal sequence is obligatory for binding.
Wassarman and co-workers have also isolated biologically active
recombinant mZP3 from murine F9 embryonal carcinoma cells (41) and
prepared specific mutant ZP3 proteins that lack biological activity
(42). This group has recently suggested that the presentation of
vicinal O-linked oligosaccharides at Ser-332 and Ser-334 is responsible for the binding interaction (10). The data we have obtained
on the structures of the O-linked oligosaccharides will facilitate future experiments addressing this important issue of
vicinal presentation. However, it is also necessary to recognize that
the genetic manipulations in F9 embryonal carcinoma cells may engender
unexpected structural changes that do not reflect the native state of
glycosylation of mZP glycoproteins.
Shur and co-workers (6, 43) propose that a sperm-specific
1-4-galactosyltransferase mediates binding by recognizing mZP3-associated O-glycans terminated with GlcNAc. Our
current results indicate the presence of minor amounts of
GlcNAc-terminated N-glycans, whereas terminal GlcNAc was not
detectable in the O-glycans. Terminal GalNAc was also found,
but it is presented in the context of Sda antigen. In
addition, the lack of D. biflorus agglutinin binding to the
mZP surface (Table VII) suggests that this
-galactosyltransferase does not have immediate access to Sda-terminated
oligosaccharides. Finally, studies performed by Lu and Shur (41)
indicate that transgenic mice lacking this specific
1-4-galactosyltransferase display 3-4-fold higher binding to eggs
compared with control mice (44). Therefore, based on all available
data, it is very unlikely that this galactosyltransferase plays any
significant role in the initial binding process.
Johnston et al. (9) recently proposed that glycans
terminated with either Gal
1-3Gal
1-4[Fuc
1-3]GlcNAc or
Lewisx-active sequences
(Gal
1-4[Fuc
1-3]GlcNAc
1-4GlcNAc) could act as high
affinity ligands that mediate initial sperm-egg binding. In addition,
these investigators also report that the trisaccharide Gal
1-4GlcNAc
1-4GlcNAc maximally inhibited sperm-egg binding by
47% at the highest tested concentration (72 µM). A
synergistic effect was observed when
Gal
1-3Gal
1-4[Fuc
1-3]GlcNAc and
Gal
1-4GlcNAc
1-4GlcNAc were included together. Based upon this
evidence, these investigators proposed that
Gal
1-3Gal
1-4[Fuc
1-3]GlcNAc could be binding to sp56, a
sperm protein previously implicated in binding to ZP3 (45). They also
suggested that another sperm-associated calcium-dependent lectin that binds terminal Gal
1-4GlcNAc sequences (46, 47) interacted with low affinity ligands like Gal
1-4GlcNAc
1-4GlcNAc (9).
Our work indicates that glycans carrying terminal
Gal
1-3Gal
1-4[Fuc
1-3]GlcNAc or
Gal
1-4[Fuc
1-3]GlcNAc are not expressed in murine ZP,
consistent with the results of a previous study (14). We have found
that fucose is attached to the N-glycans but apparently only
via
1-6 linkage to the chitobiose core. No evidence for the
fucosylation of O-glycans was found. In addition, antibodies
directed against the Lewisx sequence did not bind to eggs
obtained from transgenic mice lacking
-galactosyltransferase.3
Therefore, although the inhibition mediated by the small fucosylated oligosaccharides is genuinely interesting, it is very unlikely that
such ligands are physiologically relevant in the murine gamete binding system.
Tulsiani and co-workers (8) suggest that initial sperm-egg binding is
mediated via recognition of terminal
-mannosyl residues by a
specific sperm surface
-mannosidase. High mannose-type glycans are
located in mZP, based on the results of the present study. The
physiological relationship between this
-mannosidase and sperm
adhesion needs to be more fully investigated.
It is also significant that murine sperm will bind to surfaces other
than their homologous eggs. For example, murine sperm undergo rapid and
very tight binding to rabbit erythrocytes (48, 49). Electron microscopy
of sperm-erythrocyte interaction indicates that this binding is between
the plasma membranes of the two cell types (50). Periodate oxidation of
rabbit erythrocytes (10 mM NaIO4, 0.15 M NaCl, 1 h, 23 °C) results in a >98% reduction
in binding.4 Thus sperm
binding to rabbit erythrocytes (49) is both
carbohydrate-dependent and requires acrosome-intact sperm,
precisely the same requirements associated with murine sperm-ZP
binding. This result suggests that both sperm-erythrocyte binding and
initial sperm-egg binding involve specific lectins associated with the
plasma membrane of murine sperm.
Previous studies indicate that the O-glycans associated with
mZP3 are responsible for mediating adhesion (4, 43). Based on the
current data, the carbohydrate sequence common to mZP
O-glycans and rabbit erythrocytes is the
1-6-linked
N-acetyllactosamine (Gal
1-4GlcNAc
1-6) sequence.
Unlike red blood cells from other species, rabbit erythrocytes
profusely express branches of this type on polylactosamine sequences
associated with their glycolipids (51) and possibly their
N-glycans but not on their O-linked oligosaccharides (52). Virtually all of the rabbit erythrocyte glycolipids are also terminated with Gal
1-3Gal sequences, but murine sperm bind to rabbit erythrocytes even after exhaustive digestion with
-galactosidase (49). As stated beforehand, murine sperm-egg binding is also not dependent upon the presence of terminal
1-3-linked galactose (39, 40). If the mutation studies involving recombinant mZP3 are indeed correct (10), then vicinal presentation of
core 2 O-glycans (each presenting terminal
1-6-linked
N-acetyllactosamine units) at Ser-332 and Ser-334 could be
responsible for mediating the initial binding interaction. This
hypothesis must be thoroughly investigated.
Cahova and Draber (12) report that an IgM monoclonal antibody (Tec-02)
directed against terminal GalNAc
1-4Gal binds to murine ZP and
inhibits fertilization in a concentration-dependent manner.
However, Tec-02 did not interfere with the initial sperm-ZP binding but
did inhibit secondary binding that occurs after the induction of the
acrosome reaction. Cahova and Draber (12) therefore proposed that
glycans terminated with GalNAc
1-4Gal sequences mediate secondary
gamete binding in the mouse. In our study, we have clearly shown that
the glycans bearing terminal GalNAc
1-4Gal sequences are present but
are specifically associated with the Sda antigen. Thus the
structural data in combination with the antibody inhibition data
indicates that the secondary binding interaction may be dependent upon
the presence of the sequences terminated with the Sda
antigen. Again, this hypothesis needs to be thoroughly tested (12).
Another very significant recent observation involves the induction of
the acrosome reaction. Bovine serum albumin (BSA)-based neoglycoproteins terminated at multiple positions with a single monosaccharide (GalNAc-BSA, GlcNAc-BSA, or Man-BSA) induce the acrosome
reaction in mice (53). The current study indicates that
oligosaccharides with GalNAc, GlcNAc, or Man at the nonreducing ends
are also present in the mZP. More study will be required to determine
if mZP glycans participate in mediating signal transduction events
during murine fertilization.
Initial human sperm binding to homologous zona pellucida is inhibited
at low concentrations by glycodelin-A (54), a uterine glycoprotein with
potent immunosuppressive activities (55). Structural analysis of the
oligosaccharides associated with glycodelin-A indicate that it
expresses unusual fucosylated lacdiNAc-type sequences (GalNAc
1-4[Fuc
1-3]GlcNAc) on the majority of its glycans
(56). Oligosaccharides of this type have previously been shown to be potent inhibitors of selectin-mediated adhesions (57). Based upon these
both functional and structural studies, we suggested the possibility
that similar carbohydrate sequences are utilized during immune and
gamete recognition events in the human (56).
It is therefore significant to note in this context that the expression
of core 2 O-glycan sequences and the Sda antigen
are significantly up-regulated on interleukin-2-stimulated T
lymphocytes (58, 59) and cytotoxic T lymphocytes (60-62) in the mouse,
respectively. Another major goal in the future is to determine if the
shared expression of these carbohydrate sequences on murine ZP and
activated lymphocytes has any relevant physiological implications in
the mouse.
 |
FOOTNOTES |
*
This work was supported by a grant from the Biotechnology
and Biological Sciences Research Council (to H. R. M. and A. D.) and
a grant from the Wellcome Trust (to H. R. M. and A. D.). This study
was also supported by the Jeffress Trust (to G. F. C.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Tel.: 44 171 594 5219; Fax: 44 171 225 0458: E-mail: a.dell@ic.ac.uk (A. Dell and H. R. Morris) or Tel.: 757 446 5650; Fax: 757 624 2270; E-mail: gfc@
borg.evms.edu (G. F. Clark).
2
J. Bleil, personal communication.
3
A. Thall, personal communication.
4
M. Patankar and G. Clark, unpublished observation.
 |
ABBREVIATIONS |
The abbreviations used are:
mZP, murine zona
pellucida;
FAB, fast atom bombardment;
GC, gas chromatography;
MS, mass
spectrometry;
ZP, zona pellucida;
PNGase F, peptide
N-glycosidase F;
Hex, hexose;
HexNAc, N-acetylhexosamine;
Fuc, fucose, NeuAc,
N-acetylneuraminic acid;
NeuGc, N-glycolylneuraminic acid;
Gal, galactose;
GalNAcitol, reduced N-acetylgalactosamine;
GlcNAc, N-acetylglucosamine;
Man, mannose;
GalNAc, N-acetylgalactosamine;
Sda, NeuAc
2-3[GalNAc
1-4]Gal
1-4GlcNAc;
BSA, bovine serum
albumin.
 |
REFERENCES |
| 1.
|
Wassarman, P. M.
(1990)
Development
108,
1-17[Abstract]
|
| 2.
|
Bleil, J. D.,
and Wassarman, P. M.
(1980)
Dev. Biol.
76,
185-202[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Florman, H. M.,
Bechtol, K. B.,
and Wassarman, P. M.
(1984)
Dev. Biol.
106,
243-255[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Florman, H. M.,
and Wassarman, P. M.
(1985)
Cell
41,
313-324[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Bleil, J. D.,
and Wassarman, P. M.
(1983)
Dev. Biol.
95,
317-324[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Shur, B. D.,
and Hall, N. G.
(1982)
J. Cell Biol.
95,
574-579[Abstract/Free Full Text]
|
| 7.
|
Bleil, J. D.,
and Wassarman, P. M.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
6778-6782[Abstract/Free Full Text]
|
| 8.
|
Cornwall, G. A.,
Tulsiani, D. R.,
and Orgebin-Crist, M. C.
(1991)
Biol. Reprod.
44,
913-921[Abstract]
|
| 9.
|
Johnston, D. S.,
Wright, W. W.,
Shaper, J. H.,
Hokke, C. H.,
Van den Eijnden, D. H.,
and Joziasse, D. H.
(1998)
J. Biol. Chem.
273,
1888-1895[Abstract/Free Full Text]
|
| 10.
|
Chen, J.,
Litscher, E. S.,
and Wassarman, P. M.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
6193-6197[Abstract/Free Full Text]
|
| 11.
|
Bleil, J. D.,
Greve, J. M.,
and Wassarman, P. M.
(1988)
Dev. Biol.
128,
376-385[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Cahova, M.,
and Draber, P.
(1992)
J. Reprod. Immunol.
21,
241-256[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Nagdas, S. K.,
Araki, Y.,
Chayko, C. A.,
Orgebin-Crist, M. C.,
and Tulsiani, D. R.
(1994)
Biol. Reprod.
51,
262-272[Abstract]
|
| 14.
|
Noguchi, S.,
and Nakano, M.
(1993)
Biochim. Biophys. Acta
1158,
217-226[Medline]
[Order article via Infotrieve]
|
| 15.
|
Dell, A.,
Khoo, K.-H.,
Panico, M.,
McDowell, R. A.,
Etienne, A. T.,
Reason, A. J.,
and Morris, H. R.
(1993)
in
Glycobiology: A Practical Approach
(Fukuda, M.
, and Kobata, A., eds)
, pp. 187-222, Oxford University Press, Oxford
|
| 16.
|
Albersheim, P.,
Nevins, D. J.,
English, P. D.,
and Karr, A.
(1967)
Carbohydr. Res.
5,
340-345[CrossRef]
|
| 17.
|
Skutelsky, E.,
Ranen, E.,
and Shalgi, R.
(1994)
J. Reprod. Fertil.
100,
35-41[Abstract/Free Full Text]
|
| 18.
|
Aviles, M.,
Jaber, L.,
Castells, M. T.,
Ballesta, J.,
and Kan, F. W.
(1997)
Biol. Reprod.
57,
1155-1163[Abstract]
|
| 19.
|
Aviles, M.,
Castells, M. T.,
Abascal, I.,
Martinez-Menarguez, J. A.,
Draber, P.,
Kan, F. W.,
and Ballesta, J.
(1999)
Cell Tissue Res.
295,
269-277[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Blanchard, D.,
Cartron, J. P.,
Fournet, B.,
Montreuil, J.,
van Halbeek, H.,
and Vliegenthart, J. F.
(1983)
J. Biol. Chem.
258,
7691-7695[Abstract/Free Full Text]
|
| 21.
|
Banerjee, M.,
and Chowdhury, M.
(1997)
Mol. Hum. Reprod.
3,
109-114[Abstract/Free Full Text]
|
| 22.
|
Ozgur, K.,
Patankar, M. S.,
Oehninger, S.,
and Clark, G. F.
(1998)
Mol. Hum. Reprod.
4,
318-324[Abstract/Free Full Text]
|
| 23.
|
Mori, E.,
Mori, T.,
and Takasaki, S.
(1997)
Biochem. Biophys. Res. Commun.
238,
95-99[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Yurewicz, E. C.,
Pack, B. A.,
and Sacco, A. G.
(1991)
Mol. Reprod. Dev.
30,
126-134[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Mori, E.,
Takasaki, S.,
Hedrick, J. L.,
Wardrip, N. J.,
Mori, T.,
and Kobata, A.
(1991)
Biochemistry
30,
2078-2087[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Hirano, T.,
Takasaki, S.,
Hedrick, J. L.,
Wardrip, N. J.,
Amano, J.,
and Kobata, A.
(1993)
Eur. J. Biochem.
214,
763-769[Medline]
[Order article via Infotrieve]
|
| 27.
|
Hokke, C. H.,
Damm, J. B.,
Penninkhof, B.,
Aitken, R. J.,
Kamerling, J. P.,
and Vliegenthart, J. F.
(1994)
Eur. J. Biochem.
221,
491-512[Medline]
[Order article via Infotrieve]
|
| 28.
|
Hokke, C. H.,
Damm, J. B.,
Kamerling, J. P.,
and Vliegenthart, J. F.
(1993)
FEBS Lett.
329,
29-34[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Noguchi, S.,
and Nakano, M.
(1992)
Eur. J. Biochem.
209,
883-894[Medline]
[Order article via Infotrieve]
|
| 30.
|
Noguchi, S.,
Hatanaka, Y.,
Tobita, T.,
and Nakano, M.
(1992)
Eur. J. Biochem.
204,
1089-1100[Medline]
[Order article via Infotrieve]
|
| 31.
|
Noguchi, S.,
Hatanaka, Y.,
Tobita, T.,
and Nakano, M.
(1992)
Eur. J. Biochem.
207,
1130[Medline]
[Order article via Infotrieve]
|
| 32.
|
Yonezawa, N.,
Aoki, H.,
Hatanaka, Y.,
and Nakano, M.
(1995)
Eur. J. Biochem.
233,
35-41[Medline]
[Order article via Infotrieve]
|
| 33.
|
Katsumata, T.,
Noguchi, S.,
Yonezawa, N.,
Tanokura, M.,
and Nakano, M.
(1996)
Eur. J. Biochem.
240,
448-453[Medline]
[Order article via Infotrieve]
|
| 34.
|
Nakano, M.,
Yonezawa, N.,
Hatanaka, Y.,
and Noguchi, S.
(1996)
J. Reprod. Fertil.
50 (suppl.),
25-34
|
| 35.
|
Yonezawa, N.,
Mitsui, S.,
Kudo, K.,
and Nakano, M.
(1997)
Eur. J. Biochem.
248,
86-92[Medline]
[Order article via Infotrieve]
|
| 36.
|
Kudo, K.,
Yonezawa, N.,
Katsumata, T.,
Aoki, H.,
and Nakano, M.
(1998)
Eur. J. Biochem.
252,
492-499 |